CCS-RC (Compact Closed System – Rapid Change) - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Mixing, Granulating, Drying and Coating

DIOSNA presents a compact, closed granulation line in "Rapid Change" design.

It is a complete system for mixing, granulating and drying of pharmaceutical products in the field of R&D and clinical samples.

Interchangeable product containers of different sizes from 10l to 80l are available. The system can be designed for containment applications. All current PAT systems can be integrated. A stainless steel wall in which the HMI is implemented, builds the border to the technical area. This improves the accessibility of technical components for maintenance and reduces cleanroom space.

The exhibit can be seen at the Interpack (Düsseldorf) Hall 3/E01.

Contact: Markus Nowak, Product Manager, Pharma Systems
+49 (0)541 33104-814

Diosna Dierks & Söhne GmbH
Am Tie 23
49086 Osnabrűck
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
FindPharma Custom Search

Click here